Continuum Advisory LLC Sells 88 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Continuum Advisory LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) by 3.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 2,523 shares of the company’s stock after selling 88 shares during the period. Continuum Advisory LLC’s holdings in HCA Healthcare were worth $648,000 as of its most recent filing with the SEC.

Other large investors have also added to or reduced their stakes in the company. Prospera Financial Services Inc bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $237,000. Rockefeller Capital Management L.P. lifted its holdings in shares of HCA Healthcare by 9.0% during the third quarter. Rockefeller Capital Management L.P. now owns 6,901 shares of the company’s stock valued at $1,674,000 after acquiring an additional 572 shares during the period. Ibex Wealth Advisors bought a new stake in HCA Healthcare during the third quarter worth about $158,000. Greenleaf Trust grew its stake in HCA Healthcare by 5.2% during the third quarter. Greenleaf Trust now owns 4,421 shares of the company’s stock worth $1,073,000 after buying an additional 217 shares during the last quarter. Finally, Trexquant Investment LP increased its stake in shares of HCA Healthcare by 120.4% in the third quarter. Trexquant Investment LP now owns 20,688 shares of the company’s stock valued at $5,021,000 after buying an additional 11,301 shares in the last quarter. 67.87% of the stock is owned by institutional investors.

In other HCA Healthcare news, SVP Jennifer Berres sold 2,358 shares of the company’s stock in a transaction dated Friday, May 13th. The shares were sold at an average price of $218.87, for a total value of $516,095.46. Following the completion of the sale, the senior vice president now directly owns 11,392 shares of the company’s stock, valued at approximately $2,493,367.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Joseph A. Sowell III sold 11,522 shares of the stock in a transaction that occurred on Friday, March 11th. The shares were sold at an average price of $269.00, for a total transaction of $3,099,418.00. The disclosure for this sale can be found here. Over the last three months, insiders have bought 91,370 shares of company stock valued at $19,373,375 and have sold 14,380 shares valued at $3,723,203. Insiders own 1.50% of the company’s stock.

Shares of HCA Healthcare stock opened at $215.55 on Friday. The stock has a market cap of $63.69 billion, a price-to-earnings ratio of 10.14, a P/E/G ratio of 1.30 and a beta of 1.61. The company has a quick ratio of 1.24, a current ratio of 1.43 and a debt-to-equity ratio of 87.46. HCA Healthcare, Inc. has a twelve month low of $198.69 and a twelve month high of $279.02. The company’s fifty day moving average is $235.29 and its 200 day moving average is $243.20.

HCA Healthcare (NYSE:HCAGet Rating) last released its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.27 by ($0.15). HCA Healthcare had a net margin of 11.40% and a return on equity of 405.72%. The firm had revenue of $14.95 billion during the quarter, compared to analyst estimates of $14.72 billion. During the same quarter in the previous year, the firm earned $4.14 EPS. HCA Healthcare’s quarterly revenue was up 6.9% on a year-over-year basis. As a group, equities analysts anticipate that HCA Healthcare, Inc. will post 17.15 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a dividend of $0.56 per share. The ex-dividend date of this dividend is Wednesday, June 15th. This represents a $2.24 annualized dividend and a yield of 1.04%. HCA Healthcare’s payout ratio is 10.54%.

A number of equities research analysts have recently weighed in on HCA shares. BMO Capital Markets dropped their target price on HCA Healthcare from $275.00 to $240.00 in a research report on Tuesday, April 26th. Royal Bank of Canada dropped their target price on shares of HCA Healthcare from $291.00 to $267.00 and set an “outperform” rating for the company in a research report on Monday, April 25th. UBS Group decreased their price objective on HCA Healthcare from $289.00 to $241.00 and set a “buy” rating for the company in a report on Tuesday, April 26th. Jefferies Financial Group cut their price objective on shares of HCA Healthcare from $310.00 to $275.00 in a research report on Monday, April 25th. Finally, StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, April 25th. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare presently has an average rating of “Buy” and an average price target of $261.82.

HCA Healthcare Company Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAGet Rating).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.